FDA releases draft guidance to spur development of CDI drugs – Regulatory Focus

Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
RAPS first of its kind e-book, is a practical source depicting the importance of nutrition and the gut microbiome in noncommunicable chronic disease prevention and management.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Regulatory NewsRegulatory News | 28 October 2022 |  By 

 
Tags: CDI, clinical, FDA, trials
 
 
Regulatory Affairs Professionals Society (RAPS)
5635 Fishers Lane, Suite 400
Rockville, Maryland 20852
© 2022
Regulatory Affairs Professionals Society
 

source

Add a Comment

Your email address will not be published. Required fields are marked *